Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.5931
-0.0088 (-1.46%)
At close: Aug 10, 2026, 4:00 PM EDT
0.5862
-0.0069 (-1.16%)
After-hours: Aug 10, 2026, 6:20 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.91 million as of August 10, 2026. Its market cap has increased by 18.61% in one year.
Market Cap
3.91M
Enterprise Value
-11.54M
1-Year Change
18.61%
Ranking
Category
Stock Price
$0.59
ChartMarket Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.91M, a decrease of -97.31%. That is a compound annual growth rate of -25.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 3.91M | -4.53% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 4.82M |
| Liminatus Pharma | 4.62M |
| Mustang Bio | 4.55M |
| Revelation Biosciences | 4.46M |
| Dermata Therapeutics | 4.42M |
| PMGC Holdings | 4.16M |
| HCW Biologics | 4.07M |
| Silo Pharma | 4.05M |